Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
For the Schilling Test
Supplied lyophilized for laboratory research and third-party tested to 99%+ HPLC purity
Clinical efficacy studies of various unimolecular dual and triple agonists targeting the GLP- 1 receptor, GIP receptor, and glucagon receptor have shown promising results when used alone or in conjunction with approved hypoglycemic medications
Regulatory Status and Quality Considerations BPC-157 currently lacks approval from the United States Food and Drug Administration (FDA) or other major regulatory authorities for any therapeutic indication
Frequently Asked Questions Explore common questions about our treatment
Some research groups use both formulations in parallel to compare systemic versus enteral delivery routes within the same experimental framework
US$ 24.58
.png)
US$ 28.04
US$ 28.32
US$ 26.69
.png)
US$ 23.75
US$ 21.89
US$ 28.81
